December 29, 2025 11:30 Regulatory Bulletin from the Extraordinary General Meeting of Flerie AB (publ) on 29 December 2025 at 11:00 CET Read news release
December 29, 2025 10:30 Regulatory Bulletin from the Extraordinary General Meeting of Flerie AB (publ) on 29 December 2025 at 10:00 CET Read news release
December 11, 2025 17:00 Regulatory Flerie receives FDI-approval for the merger with Lipum Read news release
November 4, 2025 Flerie’s portfolio company Empros Pharma reports study results positioning EMP16 as a promising oral weight-loss maintenance therapy Read news release
October 8, 2025 Flerie’s portfolio company Xspray Pharma provides update on FDA process for Dasynoc®; observations at contract manufacturer delay approval Read news release
September 23, 2025 Flerie’s portfolio company Xintela has presented positive 24-month data for its stem cell product XSTEM Read news release